FindTrial
Sign In

Effect of CO2 Laser and Argon Plasma Coagulation Therapy in the Treatment of Oral Leukoplakia

Comparative evaluation of the clinical applicability of CO2 laser and argon plasma coagulation therapy in the treatment of oral leukoplakia lesion-A randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079486
Enrollment
40
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue

Interventions

Intervention1: CO2 laser Therapy: Procedure: Patient will be asked to perform a preoperative rinse with 0.2% chlorhexidine as an antiseptic measure. Administration of local anesthesia at the site of t

Sponsors

Dr Srinivasa T S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with oral leukoplakia. 2.Patient with or without habit of tobacco consumption.

Exclusion criteria

Exclusion criteria: 1.Uncooperative patients. 2. Any active oral or peri-oral viral infections. 3.Any ongoing radiation therapy.

Design outcomes

Primary

MeasureTime frame
1 Efficacy of CO2 laser treatment and APC therapy in diagnosed oral leukoplakia. Timepoint: 10 days, 3 months, 6 months, and 12 months.—

Secondary

MeasureTime frame
Recurrence rate in patient treated with CO2 laser & APC therapy in oral leukoplakia.Timepoint: 10 days, 3 months, 6 months, & 12 months.—

Countries

India

Contacts

Public ContactDr SRINIVASA T S

ALL INDIA INSTITUTE OF MEDICAL SCIENCES GORAKHPUR

seen79@rediffmail.com9993519183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026